Should You Be Adding Quantum Health Group (ASX:QTM) To Your Watchlist Today?




  • In Business
  • 2021-12-07 02:18:02Z
  • By Simply Wall St.
 

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses.

So if you're like me, you might be more interested in profitable, growing companies, like Quantum Health Group (ASX:QTM). While that doesn't make the shares worth buying at any price, you can't deny that successful capitalism requires profit, eventually. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.

Check out our latest analysis for Quantum Health Group

Quantum Health Group's Earnings Per Share Are Growing.

The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That makes EPS growth an attractive quality for any company. Impressively, Quantum Health Group has grown EPS by 26% per year, compound, in the last three years. As a general rule, we'd say that if a company can keep up that sort of growth, shareholders will be smiling.

I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. Unfortunately, Quantum Health Group's revenue dropped 5.9% last year, but the silver lining is that EBIT margins improved from 13% to 16%. That's not ideal.

In the chart below, you can see how the company has grown earnings, and revenue, over time. Click on the chart to see the exact numbers.

Quantum Health Group isn't a huge company, given its market capitalization of AU$81m. That makes it extra important to check on its balance sheet strength.

Are Quantum Health Group Insiders Aligned With All Shareholders?

Personally, I like to see high insider ownership of a company, since it suggests that it will be managed in the interests of shareholders. So we're pleased to report that Quantum Health Group insiders own a meaningful share of the business. In fact, they own 73% of the company, so they will share in the same delights and challenges experienced by the ordinary shareholders. To me this is a good sign because it suggests they will be incentivised to build value for shareholders over the long term. With that sort of holding, insiders have about AU$59m riding on the stock, at current prices. That should be more than enough to keep them focussed on creating shareholder value!

It's good to see that insiders are invested in the company, but are remuneration levels reasonable? Well, based on the CEO pay, I'd say they are indeed. I discovered that the median total compensation for the CEOs of companies like Quantum Health Group with market caps under AU$285m is about AU$409k.

The Quantum Health Group CEO received AU$308k in compensation for the year ending . That seems pretty reasonable, especially given its below the median for similar sized companies. While the level of CEO compensation isn't a huge factor in my view of the company, modest remuneration is a positive, because it suggests that the board keeps shareholder interests in mind. It can also be a sign of a culture of integrity, in a broader sense.

Does Quantum Health Group Deserve A Spot On Your Watchlist?

Given my belief that share price follows earnings per share you can easily imagine how I feel about Quantum Health Group's strong EPS growth. If you need more convincing beyond that EPS growth rate, don't forget about the reasonable remuneration and the high insider ownership. Each to their own, but I think all this makes Quantum Health Group look rather interesting indeed. We don't want to rain on the parade too much, but we did also find 1 warning sign for Quantum Health Group that you need to be mindful of.

Although Quantum Health Group certainly looks good to me, I would like it more if insiders were buying up shares. If you like to see insider buying, too, then this free list of growing companies that insiders are buying, could be exactly what you're looking for.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

COMMENTS

More Related News

Plug Power Earnings Are Coming; Here
Plug Power Earnings Are Coming; Here's What Matters

With 4Q21 earnings season kicking off, RBC's Jospeh Spak believes the quarter's results will take a back seat to 2022 guidance. And the analyst thinks...

3 Sales & Earnings Growth Winners
3 Sales & Earnings Growth Winners

3 Sales and Earnings Growth Winners

Those who invested in Big River Industries (ASX:BRI) a year ago are up 63%
Those who invested in Big River Industries (ASX:BRI) a year ago are up 63%

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...

Integra LifeSciences Holdings (NASDAQ:IART) jumps 4.4% this week, though earnings growth is still tracking behind five-year shareholder returns
Integra LifeSciences Holdings (NASDAQ:IART) jumps 4.4% this week, though earnings growth is still tracking behind five-year shareholder returns

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...

Investors in ImmunoPrecise Antibodies (CVE:IPA) have made a impressive return of 113% over the past three years
Investors in ImmunoPrecise Antibodies (CVE:IPA) have made a impressive return of 113% over the past three years

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business